• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经灌流导管射频消融治疗难治性高血压患者的肾去神经术后血压控制和临床结局:一项长达 10 年随访的病例系列研究。

Blood Pressure Control and Clinical Outcomes After Renal Denervation Through Irrigated Catheter Radiofrequency Ablation in Patients with Resistant Hypertension: A Case Series with Up to 10 Years of Follow-Up.

机构信息

Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil.

Federal University of São Paulo, São Paulo, SP, Brazil.

出版信息

High Blood Press Cardiovasc Prev. 2024 Nov;31(6):687-694. doi: 10.1007/s40292-024-00685-7. Epub 2024 Nov 18.

DOI:10.1007/s40292-024-00685-7
PMID:39557771
Abstract

INTRODUCTION

The long-term efficacy of renal denervation (RDN) has not been extensively documented.

AIM

To describe the long-term follow-up of patients after RDN.

METHODS

We evaluated patients with resistant hypertension (RH) who underwent RDN with irrigated catheter from 2012 to 2014 at a single centre. Office blood pressure (BP) and 24-hour ambulatory BP were assessed. Clinical event (stroke, myocardial infarction, need for dialysis, or death from any cause), left ventricular mass index (LVMI), estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (uACR) were evaluated.

RESULTS

The analysis included 20 individuals (age 51 ± 10 years, 75% female, ambulatory systolic BP [SBP] 168 ± 22 mmHg, ambulatory diastolic BP [DBP] 101 ± 19 mmHg, taking 7 [IQR: 6-8] antihypertensive medications). The median follow-up period was 8.5 (IQR: 5.6-9.4) years. Mean (± SD) changes from baseline were: -47 ± 41 mmHg for office SBP, -25 ± 20 mmHg for office DBP, -29 ± 26 mmHg for ambulatory SBP, and -15 ± 16 mmHg for ambulatory DBP. The number of antihypertensive drugs markedly decreased one month after RDN and a gradual upward trend was observed over time. A clinical event occurred in 9 (45%) participants. LVMI decreased from 152 ± 37 to 120 ± 31 g/m (p = 0.015), the eGFR declined from 88.9 ± 15.6 to 73.1 ± 24.2 mL/min/1.73 m (p = 0.034), and the uACR did not significantly change from baseline to follow-up.

CONCLUSIONS

In this observational study of patients with uncontrolled RH, RDN with an irrigated catheter was associated with a sustained BP reduction for up to a decade. However, a potential waning efficacy was suggested by the increasing use of antihypertensive medications over time.

摘要

介绍

肾去神经术(RDN)的长期疗效尚未得到广泛证实。

目的

描述 RDN 后患者的长期随访结果。

方法

我们评估了 2012 年至 2014 年在单中心接受灌流导管 RDN 的难治性高血压(RH)患者。评估诊室血压(BP)和 24 小时动态血压。评估临床事件(中风、心肌梗死、需要透析或任何原因导致的死亡)、左心室质量指数(LVMI)、估算肾小球滤过率(eGFR)和尿白蛋白与肌酐比值(uACR)。

结果

该分析纳入了 20 名患者(年龄 51±10 岁,75%为女性,动态收缩压[SBP]168±22mmHg,动态舒张压[DBP]101±19mmHg,服用 7[IQR:6-8]种降压药物)。中位随访时间为 8.5(IQR:5.6-9.4)年。与基线相比,平均(±SD)变化为:诊室 SBP 降低 47±41mmHg,诊室 DBP 降低 25±20mmHg,动态 SBP 降低 29±26mmHg,动态 DBP 降低 15±16mmHg。RDN 后一个月抗高血压药物的数量显著减少,且随时间呈逐渐上升趋势。9 名(45%)参与者发生临床事件。LVMI 从 152±37g/m 降至 120±31g/m(p=0.015),eGFR 从 88.9±15.6mL/min/1.73m 降至 73.1±24.2mL/min/1.73m(p=0.034),uACR 从基线到随访无显著变化。

结论

在这项对未控制的 RH 患者的观察性研究中,灌流导管 RDN 可维持长达十年的血压降低。然而,随着时间的推移,抗高血压药物的使用逐渐增加,这表明疗效可能逐渐减弱。

相似文献

1
Blood Pressure Control and Clinical Outcomes After Renal Denervation Through Irrigated Catheter Radiofrequency Ablation in Patients with Resistant Hypertension: A Case Series with Up to 10 Years of Follow-Up.经灌流导管射频消融治疗难治性高血压患者的肾去神经术后血压控制和临床结局:一项长达 10 年随访的病例系列研究。
High Blood Press Cardiovasc Prev. 2024 Nov;31(6):687-694. doi: 10.1007/s40292-024-00685-7. Epub 2024 Nov 18.
2
Catheter-Based Renal Denervation for Resistant Arterial Hypertension: 10-Year Real-World Follow-Up Data.基于导管的肾去神经术治疗难治性动脉高血压:10年真实世界随访数据
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1521-1527. doi: 10.1111/jch.14931. Epub 2024 Nov 20.
3
Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.基于导管的肾去神经术对顽固性高血压患者心脏交感神经活动及神经支配的影响。
Clin Res Cardiol. 2016 Apr;105(4):364-71. doi: 10.1007/s00392-015-0930-4. Epub 2015 Oct 22.
4
Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.酒精介导的肾脏去神经术对降压药物治疗下血压的影响:来自 TARGET BP I 随机临床试验的主要结果。
Circulation. 2024 Jun 11;149(24):1875-1884. doi: 10.1161/CIRCULATIONAHA.124.069291. Epub 2024 Apr 8.
5
Renal Denervation Effects on Blood Pressure in Resistant and Uncontrolled Hypertension: A Meta-Analysis of Sham-Controlled Randomized Clinical Trials.肾去神经支配对顽固性和未控制高血压患者血压的影响:一项假手术对照随机临床试验的荟萃分析。
Clin Cardiol. 2025 Mar;48(3):e70104. doi: 10.1002/clc.70104.
6
Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.基于导管的肾去神经术治疗耐药性高血压的超长期疗效和安全性:10 年随访结果。
Clin Res Cardiol. 2024 Oct;113(10):1384-1392. doi: 10.1007/s00392-024-02417-2. Epub 2024 Mar 7.
7
Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis.基于射频的肾脏去神经术治疗耐药性高血压患者的疗效和安全性:系统评价和荟萃分析。
High Blood Press Cardiovasc Prev. 2024 Jul;31(4):329-340. doi: 10.1007/s40292-024-00660-2. Epub 2024 Jun 19.
8
Renal artery sympathetic denervation: observations from the UK experience.肾动脉交感神经去神经支配:来自英国经验的观察结果。
Clin Res Cardiol. 2016 Jun;105(6):544-52. doi: 10.1007/s00392-015-0959-4. Epub 2016 Jan 22.
9
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.现实世界中的肾交感神经去神经支配治疗:海德堡注册研究结果
Clin Res Cardiol. 2014 Feb;103(2):117-24. doi: 10.1007/s00392-013-0627-5. Epub 2013 Oct 15.
10
Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.基于导管的射频肾去神经支配术后动态血压降低的解剖学和操作决定因素
Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):845-851. doi: 10.1016/j.carrev.2018.02.016. Epub 2018 Mar 2.

引用本文的文献

1
Impact of sympathetic denervation via paraaortic lymphadenectomy on blood pressure in endometrial cancer patients.经腹主动脉旁淋巴结清扫术进行交感神经去神经支配对子宫内膜癌患者血压的影响。
Turk J Obstet Gynecol. 2025 Mar 10;22(1):13-18. doi: 10.4274/tjod.galenos.2025.32654.

本文引用的文献

1
Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis.基于导管的肾脏去神经支配后的长期血压降低:系统评价和荟萃分析。
Hypertension. 2024 Jun;81(6):e63-e70. doi: 10.1161/HYPERTENSIONAHA.123.22314. Epub 2024 Mar 20.
2
Impact of renal denervation on cardiac remodeling in resistant hypertension: A meta-analysis.肾去神经术对耐药性高血压中心脏重构的影响:一项荟萃分析。
Clin Cardiol. 2024 Feb;47(2):e24222. doi: 10.1002/clc.24222.
3
Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
极高危高血压患者行肾交感神经切除术的 10 年随访。
J Hypertens. 2024 May 1;42(5):801-808. doi: 10.1097/HJH.0000000000003650. Epub 2023 Dec 20.
4
Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the Symplicity Spyral Renal Denervation System.2023 年 FDA 循环系统设备顾问专家组会议概述:Symplicity Spyral 肾脏去神经系统。
Am Heart J. 2024 Mar;269:108-117. doi: 10.1016/j.ahj.2023.12.005. Epub 2023 Dec 20.
5
Renal Denervation in the Management of Resistant Hypertension: A Comprehensive Review of Literature.肾动脉去神经术在难治性高血压治疗中的应用:文献综述。
Curr Probl Cardiol. 2024 Feb;49(2):102137. doi: 10.1016/j.cpcardiol.2023.102137. Epub 2023 Oct 18.
6
Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements.肾交感神经去神经术的安全性和有效性:24小时动态血压测量的9年长期随访
Front Cardiovasc Med. 2023 Jun 19;10:1210801. doi: 10.3389/fcvm.2023.1210801. eCollection 2023.
7
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
8
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).经导管去肾交感神经术治疗成人高血压管理:欧洲心脏病学会(ESC)高血压理事会和欧洲经皮心血管介入学会(EAPCI)的临床共识声明。
EuroIntervention. 2023 Mar 20;18(15):1227-1243. doi: 10.4244/EIJ-D-22-00723.
9
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.基于导管的肾去神经支配:顽固性高血压患者9年安全性及血压降低随访数据
Hypertension. 2023 Apr;80(4):811-819. doi: 10.1161/HYPERTENSIONAHA.122.20853. Epub 2023 Feb 10.
10
10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension.顽固性高血压患者经导管肾去神经术的10年随访结果
J Am Coll Cardiol. 2023 Feb 7;81(5):517-519. doi: 10.1016/j.jacc.2022.11.038.